1. Home
  2. SRPT vs PBI Comparison

SRPT vs PBI Comparison

Compare SRPT & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$18.68

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

HOLD

Current Price

$16.41

Market Cap

2.3B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRPT
PBI
Founded
1980
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2000
1994

Fundamental Metrics

Financial Performance
Metric
SRPT
PBI
Price
$18.68
$16.41
Analyst Decision
Hold
Hold
Analyst Count
29
3
Target Price
★ $25.85
$13.00
AVG Volume (30 Days)
★ 3.0M
1.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
★ 2.29%
EPS Growth
N/A
★ 175.00
EPS
★ 2.99
0.75
Revenue
★ $2,198,237,000.00
$1,892,629,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $6.15
$21.81
Revenue Growth
★ 15.58
N/A
52 Week Low
$14.68
$8.95
52 Week High
$25.32
$19.07

Technical Indicators

Market Signals
Indicator
SRPT
PBI
Relative Strength Index (RSI) 43.84 40.79
Support Level $15.40 $15.09
Resistance Level $23.80 $16.56
Average True Range (ATR) 1.30 0.41
MACD -0.41 -0.09
Stochastic Oscillator 13.06 23.99

Price Performance

Historical Comparison
SRPT
PBI

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.

Share on Social Networks: